UK biotech Engitix has raised a $25 million series A extension from existing investor Netherton Investments, investing on behalf of BlueCrest Capital Management co-founder Mike Platt. The funding will ...

Proteomic mass spectrometry can identify key biomarkers in IPF, aiding in diagnosis and prognosis despite the disease's ...

A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together ...

Detecting cancer in the earliest stages could dramatically reduce cancer deaths because cancers are usually easier to treat ...

When a person suffers a stroke, physicians must restore blood flow to the brain as quickly as possible to save their life.

The study shows that this drug pair works far better together than either agent alone, offering a realistic and potentially fast path toward a new ...

Detecting cancer in the earliest stages could dramatically reduce cancer deaths because cancers are usually easier to treat when caught early.

When a person suffers a stroke, physicians must restore blood flow to the brain as quickly as possible to save their life.